Naevus ยท HamartomaICD-10 D22 / Q82.5

Becker naevus

Becker's melanosis; pigmented hairy epidermal nevus; "Becker melanosis"; (in extensive form, Becker's naevus syndrome)

The Becker naevus โ€” first described by SW Becker in 1949 โ€” is a common acquired or rarely congenital cutaneous hamartoma, classically presenting in adolescence as a unilateral, well-demarcated, irregularly bordered, brown hyperpigmented patch (5โ€“20 cm) on the shoulder, scapula or upper anterior chest of a young man, with progressive development of overlying terminal hypertrichosis from puberty onwards. Recent molecular work has demonstrated postzygotic somatic mosaic activating mutations of ACTB (ฮฒ-actin) โ€” placing Becker naevus among the postzygotic somatic mosaic disorders alongside naevus sebaceus (HRAS/KRAS) and naevus spilus (HRAS). Becker naevus is benign with no documented malignant potential of clinical significance โ€” but the clinical entity often presents diagnostic confusion with congenital melanocytic naevus, cafรฉ-au-lait macule (NF1) and segmental hyperpigmentation. Becker's naevus syndrome is a rare extended phenotype with ipsilateral hypoplasia of breast, pectoralis muscle or limb, scoliosis or other skeletal anomalies.

CurrentLast reviewed 26 April 2026
Clinical image of Becker naevus
Becker naevus. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Clinical features

  • Unilateral, well-demarcated, irregularly bordered, brown to tan hyperpigmented patch.
  • Size 5โ€“20 cm; occasionally smaller or much larger.
  • Distribution โ€” shoulder, scapula, upper anterior chest, deltoid; less often face, lower back, abdomen, lower limb.
  • Onset typically in adolescence (10โ€“20 years); occasionally congenital.
  • M:F ~5:1; cosmetic concern is the principal presenting issue.
  • Hypertrichosis โ€” terminal hairs develop within the lesion from puberty (testosterone-driven); often the most cosmetically intrusive feature for boys.
  • Surface texture โ€” slightly rough; occasional acne-like papules within the lesion (driven by sebaceous gland hyperplasia within the affected area).
  • Becker's naevus syndrome โ€” extensive Becker's naevus + ipsilateral hypoplasia of breast tissue, pectoralis major / pectoralis minor, scoliosis, accessory cervical ribs, leg-length discrepancy or other skeletal anomalies.

Genetics & pathogenesis

  • Postzygotic somatic mosaic gain-of-function mutations of ACTB (ฮฒ-actin) โ€” ~70% of cases tested.
  • Confined to the affected lesion.
  • Driver of the increased local androgen receptor expression that produces the hypertrichosis and acneiform features.
  • Joins naevus sebaceus (HRAS / KRAS), naevus spilus (HRAS) and Schimmelpenning syndrome (HRAS) in the spectrum of postzygotic somatic mosaic skin hamartomas.

Histology

  • Epidermal hyperpigmentation with mild acanthosis.
  • Increased basal-layer melanin; melanocyte numbers normal or only mildly increased.
  • Smooth-muscle hyperplasia (arrector pili) โ€” characteristic and diagnostic.
  • Increased sebaceous and apocrine glands.
  • Increased pilosebaceous units accounting for the hypertrichosis.
  • No atypia.

Cancer risk

  • Becker naevus is benign with no documented melanoma risk above background.
  • Rare reports of melanoma arising within Becker naevus exist but are no more frequent than melanoma in similar areas of unaffected skin โ€” most experts consider any apparent association coincidental.
  • Surveillance is therefore not specifically indicated for cancer; however, reassurance and routine skin surveillance per the patient's overall melanoma risk are appropriate.

Management

  • Reassurance โ€” Becker naevus is benign and stable in adulthood; no cancer surveillance indicated.
  • Cosmetic management of pigmentation:
    • Q-switched lasers (Nd:YAG 1064 nm, ruby 694 nm, alexandrite 755 nm) โ€” variable response; multiple sessions; risk of post-inflammatory hyperpigmentation.
    • Picosecond lasers โ€” emerging.
    • Topical depigmenting agents โ€” limited efficacy.
    • Camouflage cosmetics.
  • Cosmetic management of hypertrichosis:
    • Long-pulsed alexandrite 755 nm or diode 810 nm laser hair reduction โ€” first-line; multiple sessions.
    • Electrolysis for finer control.
    • Topical eflornithine (limited).
  • Becker's naevus syndrome โ€” orthopaedic, plastic / breast surgery and physiotherapy MDT for the structural anomalies; corrective surgery as appropriate.
  • Genetic counselling โ€” somatic mosaic; not heritable; recurrence risk negligible.

References

  1. Becker SW. Concurrent melanosis and hypertrichosis in a distribution of nevus unius lateris. Arch Dermatol Syphilol; 1949.
  2. Cai ED et al. Postzygotic mutations in beta-actin are associated with Becker's nevus and Becker's nevus syndrome. J Invest Dermatol; 2017.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.